Replies to post #324880 on NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

anders2211 you are absolutely right about that that Novocure had a MC of 5 billion 6 months after TLD, [and about $2 billion before TLD.]

BTW, as the rule of thumb, a drug/therapeutic vaccine company is usually value much much higher than a device company for obvious reasons.

So at least we should be valued much higher than Novocure.